Pluripotential GluN1 (NMDA NR1): Functional Significance in Cellular Nuclei in Pain/Nociception.

Humans Cell Nucleus Excitatory Amino Acid Agonists N-Methylaspartate Nociception Pain Receptors, N-Methyl-D-Aspartate / genetics
central sensitization epigenetics glutamate inflammation membrane trafficking memory mood nuclear translocation nucleolar stress nucleolus nucleus pain

Journal

International journal of molecular sciences
ISSN: 1422-0067
Titre abrégé: Int J Mol Sci
Pays: Switzerland
ID NLM: 101092791

Informations de publication

Date de publication:
25 Aug 2023
Historique:
received: 16 07 2023
revised: 18 08 2023
accepted: 23 08 2023
medline: 11 9 2023
pubmed: 9 9 2023
entrez: 9 9 2023
Statut: epublish

Résumé

The

Identifiants

DOI: 10.3390/ijms241713196 PMID: 37686003 PMC: PMC10488196
pubmed: 37686003
pii: ijms241713196
doi: 10.3390/ijms241713196
pmc: PMC10488196
pii:
doi:

Substances chimiques

Excitatory Amino Acid Agonists 0
N-Methylaspartate 6384-92-5
Receptors, N-Methyl-D-Aspartate 0
GRIN1 protein, human 0

Types de publication

Journal Article Review

Langues

eng

Sous-ensembles de citation

IM

Subventions

Organisme : NINDS NIH HHS
ID : R01 NS032778
Pays : United States
Organisme : BLRD VA
ID : I01 BX002695
Pays : United States
Organisme : NIH HHS
ID : NS11255
Pays : United States
Organisme : NINDS NIH HHS
ID : P01 NS011255
Pays : United States
Organisme : NIAMS NIH HHS
ID : R21 AR048371
Pays : United States

Références

Epigenomics. 2020 Nov;12(22):1983-1997
pubmed: 33242253
Exp Brain Res. 2009 Jun;196(1):5-11
pubmed: 19294370
Front Mol Neurosci. 2013 May 28;6:14
pubmed: 23754976
J Neurochem. 2003 Dec;87(5):1066-75
pubmed: 14622087
J Rheumatol. 2000 Mar;27(3):739-45
pubmed: 10743819
Blood. 2003 Aug 15;102(4):1254-9
pubmed: 12649130
Pain. 2004 Nov;112(1-2):131-41
pubmed: 15494193
Nature. 2003 Aug 21;424(6951):938-42
pubmed: 12931188
FASEB J. 1999 Dec;13(15):2179-85
pubmed: 10593865
Acta Pharmacol Sin. 2011 Feb;32(2):160-6
pubmed: 21293467
Phytother Res. 2019 Feb;33(2):431-441
pubmed: 30450837
Pain. 1992 Nov;51(2):249-253
pubmed: 1484720
Neurol Res. 2017 Nov;39(11):1006-1013
pubmed: 28814157
Oncotarget. 2018 May 4;9(34):23373-23389
pubmed: 29805740
J Neurochem. 1988 Jul;51(1):127-32
pubmed: 2898001
Arthritis Rheum. 2007 Aug;56(8):2523-34
pubmed: 17665433
Molecules. 2022 Jul 19;27(14):
pubmed: 35889472
Semin Cell Dev Biol. 2023 Feb 28;136:64-74
pubmed: 35410715
Neuroreport. 1996 Nov 4;7(15-17):2581-5
pubmed: 8981427
Brain Behav Immun. 2017 Mar;61:80-95
pubmed: 28011263
J Affect Disord. 2023 Aug 15;335:484-492
pubmed: 37201900
Stem Cells Dev. 2017 Jun 1;26(11):798-807
pubmed: 28381110
J Neurochem. 2011 Nov;119(4):815-25
pubmed: 21883224
Sci Rep. 2018 Jan 25;8(1):1610
pubmed: 29371613
Acta Neuropathol Commun. 2019 Apr 8;7(1):54
pubmed: 30961664
Circ Heart Fail. 2016 Nov;9(11):
pubmed: 27810863
Front Immunol. 2022 Jan 12;12:762743
pubmed: 35095841
Neurochem Int. 2012 Jan;60(1):55-67
pubmed: 22080157
J Neurosci. 1996 Jul 1;16(13):4283-92
pubmed: 8753889
Neurosci Lett. 1993 Jan 4;149(1):99-102
pubmed: 8097022
Int J Mol Sci. 2019 Sep 06;20(18):
pubmed: 31500132
Bone. 1998 Apr;22(4):295-9
pubmed: 9556127
Biomed Res Int. 2022 Aug 16;2022:5274375
pubmed: 36017378
Pain. 2009 Jan;141(1-2):97-103
pubmed: 19058915
Biophys Rev. 2020 Oct;12(5):1093-1106
pubmed: 33064286
Neurosci Lett. 2000 Jul 14;288(2):163-6
pubmed: 10876086
J Pharmacol Exp Ther. 2007 Sep;322(3):982-8
pubmed: 17551091
Acta Neurochir (Wien). 2004 Aug;146(8):819-30
pubmed: 15254804
Nature. 2005 Dec 22;438(7071):1167-71
pubmed: 16372012
J Biol Chem. 2005 Oct 14;280(41):35018-27
pubmed: 16049015
Pain. 2011 Mar;152(3):573-581
pubmed: 21239115
Neuron. 2004 Dec 16;44(6):997-1009
pubmed: 15603742
J Neurochem. 2002 Jun;81(6):1152-65
pubmed: 12068064
Int J Mol Sci. 2018 Jun 30;19(7):
pubmed: 29966365
Int J Mol Sci. 2021 Aug 28;22(17):
pubmed: 34502266
J Neurochem. 2001 Jul;78(2):254-64
pubmed: 11461961
Evid Based Complement Alternat Med. 2019 Feb 03;2019:4213928
pubmed: 30854008
J Mol Neurosci. 2021 Jul;71(7):1436-1455
pubmed: 33829390
Int J Mol Sci. 2022 Jan 11;23(2):
pubmed: 35054943
Front Physiol. 2020 May 27;11:440
pubmed: 32536874
Acta Histochem. 2013 Jan;115(1):42-7
pubmed: 22512920
Neurol Sci. 2022 Jul;43(7):4107-4124
pubmed: 35461471
Cell Mol Neurobiol. 2023 Jan;43(1):139-153
pubmed: 34978648
J Pharmacol Sci. 2017 Jan;133(1):34-41
pubmed: 28087150
Parkinsons Dis. 2011;2011:216298
pubmed: 21603248
Oncotarget. 2017 Oct 29;8(57):96536-96552
pubmed: 29228551
J Food Biochem. 2022 Aug;46(8):e14182
pubmed: 35415913
Pharmacol Biochem Behav. 2004 Sep;79(1):183-8
pubmed: 15388298
J Biol Chem. 1998 Nov 6;273(45):29394-9
pubmed: 9792641
Brain Res. 1994 Nov 21;664(1-2):77-84
pubmed: 7895049
J Neurochem. 2005 Aug;94(3):713-22
pubmed: 16000165
Clin Exp Immunol. 2004 Sep;137(3):621-7
pubmed: 15320917
Cells. 2019 Jul 26;8(8):
pubmed: 31357498
Pain. 2000 May;86(1-2):69-74
pubmed: 10779662
Brain Res. 2009 Jul 7;1279:109-20
pubmed: 19406112
Neurol Res. 2018 Apr;40(4):318-323
pubmed: 29473447
Front Neurosci. 2015 Dec 16;9:469
pubmed: 26733784
J Neurophysiol. 1993 Oct;70(4):1365-77
pubmed: 7904298
Cells. 2022 Sep 27;11(19):
pubmed: 36230979
J Neurophysiol. 2008 Jan;99(1):122-32
pubmed: 18003876
ACS Chem Neurosci. 2022 Feb 16;13(4):432-441
pubmed: 35107991
Pain Med. 2012 Nov;13(11):1474-90
pubmed: 22978429
J Neurosci. 2003 Jun 15;23(12):5031-40
pubmed: 12832526
J Clin Med. 2023 May 02;12(9):
pubmed: 37176696
Anticancer Res. 1999 Sep-Oct;19(5B):4193-8
pubmed: 10628374
Mol Biol Evol. 2008 Mar;25(3):580-90
pubmed: 18178970
Am J Physiol Regul Integr Comp Physiol. 2010 Mar;298(3):R584-98
pubmed: 20007519
Cell Mol Neurobiol. 2010 Aug;30(6):901-7
pubmed: 20414717
Brain Res Brain Res Rev. 1992 Jan-Apr;17(1):39-50
pubmed: 1638274
J Neurosci. 2009 Dec 16;29(50):15613-20
pubmed: 20016075
J Exp Zool A Ecol Genet Physiol. 2009 Dec 1;311(10):763-75
pubmed: 19658087
J Invest Dermatol. 1999 Mar;112(3):337-42
pubmed: 10084312
Proc Natl Acad Sci U S A. 2015 Dec 1;112(48):14960-5
pubmed: 26627246
Neuron. 2006 Apr 6;50(1):9-11
pubmed: 16600850
Biochem Biophys Res Commun. 2021 Jan 1;534:323-329
pubmed: 33248694
J Biol Chem. 2002 Jan 11;277(2):1457-68
pubmed: 11700309
Neurosci Lett. 2016 Jan 12;611:51-8
pubmed: 26610904
J Neuroinflammation. 2015 Aug 20;12:151
pubmed: 26289587
Front Cell Neurosci. 2022 Sep 27;16:999509
pubmed: 36238833
Mol Neurobiol. 2021 Nov;58(11):5986-6005
pubmed: 34432266
Nucleic Acids Res. 2022 Jan 7;50(D1):D1282-D1294
pubmed: 34718737
J Neurocytol. 2000 Jul;29(7):509-23
pubmed: 11279366
Mol Neurobiol. 2017 Oct;54(8):6133-6147
pubmed: 27699604
Pharmacol Rev. 2021 Oct;73(4):298-487
pubmed: 34753794
Proc Natl Acad Sci U S A. 2008 Sep 16;105(37):14163-8
pubmed: 18779583
Front Cell Neurosci. 2018 Oct 02;12:334
pubmed: 30333730

Auteurs

Terry A McNearney (TA)

Department of Neuroscience and Cell Biology, University of Texas Medical Branch Galveston, Galveston, TX 77555-1043, USA.
Department of Internal Medicine, University of Texas Medical Branch Galveston, Galveston, TX 77555-1043, USA.
Department of Microbiology and Immunology, University of Texas Medical Branch Galveston, Galveston, TX 77555-1043, USA.

Karin N Westlund (KN)

Department of Anesthesiology, University of New Mexico Health Sciences Center, Albuquerque, NM 87131-0001, USA.
Biomedical Laboratory Research & Development (121F), New Mexico VA Health Care System, Albuquerque, NM 87108-5153, USA.
ORCID: 0000-0002-7388-4834

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Pluripotential GluN1 (NMDA NR1): Functional...
questionsmedicales.fr › Cellules › Structures cellulaires › Espace intracellulaire › Cytoplasme › Structures cytoplasmiques › Organites › Noyau de la cellule › Pluripotential GluN1 (NMDA NR1): Functional...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Effets physiologiques des médicaments › Agents neuromédiateurs › Agents des acides aminés excitateurs › Agonistes des acides aminés excitateurs › Pluripotential GluN1 (NMDA NR1): Functional...
questionsmedicales.fr › Acides aminés, peptides et protéines › Acides aminés › Acides aminés dicarboxyliques › N-Méthyl-aspartate › Pluripotential GluN1 (NMDA NR1): Functional...
questionsmedicales.fr › Phénomènes psychologiques › Processus mentaux › Perception › Perception de la douleur › Nociception › Pluripotential GluN1 (NMDA NR1): Functional...
questionsmedicales.fr › Phénomènes physiologiques de l'appareil locomoteur et du système nerveux › Phénomènes physiologiques du système nerveux › Sensation › Douleur › Pluripotential GluN1 (NMDA NR1): Functional...
questionsmedicales.fr › Acides aminés, peptides et protéines › Protéines › Protéines membranaires › Récepteurs de surface cellulaire › Récepteurs aux neuromédiateurs › Récepteurs aux acides aminés › Récepteurs au glutamate › Récepteurs ionotropes du glutamate › Récepteurs du N-méthyl-D-aspartate › Pluripotential GluN1 (NMDA NR1): Functional...